• Acute Myeloid Leukemia

Dr. Benton is a board-certified hematologist and medical oncologist who joined RMCC in 2019 after serving on faculty at MD Anderson Cancer Center in the Department of Leukemia. He specializes in blood cancers and non-cancerous blood disorders, with an emphasis on acute and chronic leukemias. He uses personalized medicine to treat each unique cancer, delivering high-quality and compassionate care for his patients. Dr. Benton has authored countless peer-reviewed publications and presented original research and trial data at local, national, and international meetings relating to blood cancers, molecular genomics, and clinical research. His areas of expertise include chemotherapy and new therapies including molecular targeted therapy, antibody therapy, immunotherapy epigenetic therapy, cell therapy, oral therapy, and novel combinations. Dr. Benton serves as a principal investigator for many clinical research trials which have paved the way for cutting-edge cancer treatments. He serves on the USON Research Committee and leads the Citywide Hematology Tumor Board in Denver-Metro area.